Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05094752
Other study ID # 2020-A02015-34
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 20, 2021
Est. completion date September 20, 2024

Study information

Verified date September 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

"Spinal cord injury (SCI) is a dramatic event resulting in a long-term handicap. Appropriate care from admission to the intensive care unit (ICU) is a key element not only for the survival of these patients but also to promote their recovery. Moreover, the studies on natural history of SCI have shown that most of the recovery occurs within the first 3 to 6 months post-injury. This period is therefore crucial for these patients. However, the environment of the ICU and the acute condition of the patients limit the rehabilitation possibilities. In such a context, functional proprioceptive stimulations (Vibramoov™ system, Techno Concept, France) could be a tool of interest. By using tendon vibrations, the Vibramoov™ system allows to reproduce the proprioceptive signatures of cyclic movements such as walking. Some studies have already demonstrated the benefits of proprioceptive vibrations. However, so far, these benefits have only been studied at the chronic stage of neurological diseases. The investigators hypothesized that early functional proprioceptive stimulations (FPS) may reduce spasticity and promote sensorimotor recovery in tetraplegic and high paraplegic patients. To test their hypothesis, the investigators conduct a randomized controlled trial on 40 patients with traumatic SCI. These patients will be stratified into two groups according to the completeness of their lesion. Every patient will be included within ten days post-injury and receive either FPS, either sham stimulations to the joints of the lower limbs, 4 times a week during 8 weeks. the primary outcome measures will assess spasticity. the investigators also assess sensorimotor recovery, pain, muscle wasting, cognitive impairment and functional status. "


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date September 20, 2024
Est. primary completion date September 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - • Traumatic Spinal Cord Injury at or above level T6 - Age = 18 years old - No pregnancy - Not being under guardianship - Be affiliated to the French social security system Exclusion Criteria: - Orthopedic lesions or any medical condition that prevent the implementation of the protocol within ten days post-injury - Severe brain injury

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Proprioceptive stimulations
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the intervention group will receive proprioceptive stimulations set to create illusions of movement.
Sham stimulations
Vibration treatment will last eight weeks for each patient, with 4 sessions per week, 30 minutes per session. Subjects of the control group will receive sham stimulations.

Locations

Country Name City State
France Bicêtre Hospital Le Kremlin-Bicêtre

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the modified Ashworth scale (MAS) The MAS enables to assess spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the angles of the muscle reaction in the modified Tardieu scale (MTS) The MTS enables to assess the severity of spasticity. The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (The outcome is reported in degree, from 0 to 180 degrees, higher values represent a higher dynamic component of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the quality of the muscle reaction in the modified Tardieu scale (MTS) The muscle whose spasticity will be assessed are the soleus, gastrocnemius, knee extensors, knee flexors, adductors and gracilis (Score range from 0 to 5 per muscle, higher values represent a higher severity of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Primary Changes in the Spinal cord assessment tool for spastic reflexes (SCATS) This score enables to asses global spasticity (Score range from 0 to 18, higher values represent a higher degree of spasticity) Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary Changes in the visual analog scale for the auto-assessment of problematic spasticity Score range from 0 to 100, higher values represent a higher degree of problematic spasticity. Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury.
Secondary Changes in the visual analog scale for the auto-assessment of pain Score range from 0 to 100, higher values represent a higher intensity of pain. Every week during the eight weeks of treatment, then at 2 months (end of treatment), 6 months and 1 year after the injury
Secondary Changes in the International standards for neurological classification of spinal cord injury (ISNCSCI) score This score enables to assess sensorimotor recovery (Score range from 0 to 324, higher values represent a better outcome) At inclusion, and at one week, one month, 2 months, 6 months and 1 year after the injury.
Secondary Changes in the quadriceps muscle thickness "Measured with ultrasound, average of two measures (at the border between the lower third and upper two-thirds between the anterior superior iliac spine and the upper pole of the patella, and at the midpoint between the anterior superior iliac spine and the upper pole of the patella) (Measure in centimeters, higher values represent a better outcome)" At inclusion, then twice a week during the first month, and at 2 months, 6 months and 1 year after the injury
Secondary Changes in the nitrogen balance, Marker of protein losses (Measure in mmol/L, lower values represent a better outcome) Every 48 hours during the first two weeks, and then once a week for six weeks
Secondary Number of days between the SCI and the verticalization at 45° The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome) Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Secondary Number of days between the SCI and the verticalization at 70° The attempt is successful if the position is maintained for 5 minutes without adverse effect. The verticalization protocol will remain the same as the one commonly used in the ICU. According to this protocol, verticalization will be progressive and mean blood pressure will be monitored continuously. The attempt is stopped if the patient feels unwell (signs of intolerance) or if the mean blood pressure drops by more than 20% (Measure in days, higher values represent a lower outcome) Verticalization is attempted progressively 3 times a week during the 8 weeks of treatment.
Secondary Changes in the Spinal cord independence measure (SCIM) This measure enables to assess functional status (Score range from 0 to 100, higher values represent a better outcome) At 2 months, 6 months and 1 year after the injury
Secondary Changes in the Montreal cognitive assessment (MoCA) This measure enables to assess cognitive impairments (Score range from 0 to 30, higher values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the time to complete the bells cancellation test to assess cognitive impairments This measure enables to assess cognitive impairments (Measure in minutes and seconds, lower values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the number of omissions in the bells cancellation test to assess cognitive impairments This measure enables to assess cognitive impairments (Lower values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
Secondary Changes in the digit span test to assess cognitive impairments This measure enables to assess cognitive impairments (Higher values represent a better outcome) Up to 1 month, then at 2 months and 1 year after the injury
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06321172 - Muscle and Bone Changes After 6 Months of FES Cycling N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05484557 - Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Not yet recruiting NCT05506657 - Early Intervention to Promote Return to Work for People With Spinal Cord Injury N/A
Recruiting NCT03680872 - Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System N/A
Recruiting NCT04105114 - Transformation of Paralysis to Stepping Early Phase 1
Completed NCT04221373 - Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT03898700 - Coaching for Caregivers of Children With Spinal Cord Injury N/A
Recruiting NCT04883463 - Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury N/A
Active, not recruiting NCT04881565 - Losing Balance to Prevent Falls After Spinal Cord Injury (RBT+FES) N/A
Completed NCT04864262 - Photovoice for Spinal Cord Injury to Prevent Falls N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Active, not recruiting NCT04544761 - Resilience in Persons Following Spinal Cord Injury
Terminated NCT03170557 - Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation N/A
Completed NCT03220451 - Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients N/A
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Recruiting NCT04736849 - Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury N/A